Catalyst Clinical Research Europe, Ltd.

Active08872035 Private limited company
Incorporated
31 January 2014 (12 years)
Previously known as
Aptus Clinical Limited (until 27 April 2023)
Industry
Research and experimental development on biotechnology (72110)
Accounts type
Medium
Region
East Midlands
Address
4th Floor
East West
Tollhouse Hill
NG1 5FS

Filing status

Accounts due
31 December 2026
Last accounts
31 December 2024
Conf. stmt due
4 February 2027
Last conf. stmt
21 January 2026

Charges

Total
4
Outstanding
0
Part satisfied
0
Satisfied
4

Officers 3 active

Officer details are public data from the Companies House register.

Lewis, Gabrielle
Director · Appointed 13 February 2026
American
Born October 1984 (42)
Director · Appointed 13 February 2026
British
Born February 1970 (56)
Director · Appointed 13 February 2026
British
Born July 1985 (41)
Officer history (5 former)
13 February 2026
Resigned Mcnamara, Patricia Bronke as Director
13 February 2026
Appointed Macdonald, Alistair John as Director
13 February 2026
Appointed Merriman, Anthony Jason as Director
13 February 2026
Appointed Lewis, Gabrielle as Director
13 February 2026
Resigned Dyer, Nicholas as Director
29 April 2022
Appointed Dyer, Nicholas as Director
29 April 2022
Appointed Mcnamara, Patricia Bronke as Director
29 April 2022
Resigned Cawley, Anita as Director
29 April 2022
Resigned Lewis, Jonathan as Director
29 April 2022
Resigned Mcconchie, Stephen as Director
31 January 2014
Appointed Cawley, Anita as Director
31 January 2014
Appointed Lewis, Jonathan as Director
31 January 2014
Appointed Mcconchie, Stephen as Director

Ownership 0 active

People and entities with significant control, from the Companies House PSC register

The company has declared that it has no person with significant control.
Former controllers (4)
22 September 2022
Ceased Catalyst Clinical Research, LLC — Owns 75–100% of shares
12 September 2022
Ceased Project Constellation Holdings, Inc. — Owns 25–50% of shares
29 April 2022
Ceased Jonathan Lewis — Owns 25–50% of shares
29 April 2022
Ceased Stephen Mcconchie — Owns 25–50% of shares

Financials

Net Assets
(£913,249)
Cash
£799,872
Employees
52
Debt Ratio
133%
Current Ratio
0.7x

Trend

Net Assets
(£1.0M) (£500k) £0 £500k 2020 2021 2022 2023 £320,617 £65,382 (£441,199) (£913,249)
Balance sheet detail
20232022202220212020
Fixed Assets£109,872£27,161£32,077£30,582£34,656
Current Assets£2,656,089£1,356,888£1,915,500£1,568,248
Debtors£1,856,217£983,998£985,107£738,489£834,952
Cash£799,872£354,248£371,781£1,177,011£733,296
Creditors (< 1 year)£3,651,742£1,830,164£1,548,031£1,172,384
Creditors (> 1 year)£0£326,858£103,318
Net Current Assets(£995,653)(£473,276)£367,469£395,864
Net Assets(£913,249)(£441,199)£65,382£320,617
Shareholder Funds(£913,249)(£441,199)£65,382£320,617

Filings 90

DateDescriptionMade Up ToPagesPDF
23 April 2026Registered office address changed
17 February 2026Satisfaction of a charge in full
17 February 2026Satisfaction of a charge in full
16 February 2026Appointment of a director
16 February 2026Appointment of a director
Show all 90 filings

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?